SCHEMBL5159892

SCHEMBL5159892

COC(=O)c1cccc(C)c1NS(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 6/20 0.74
LMNA P02545 3/20 0.70
KEAP1 Q14145 1/20 0.58
TCF4 P15884 1/20 0.57
CTNNB1 P35222 1/20 0.57
ALDH1A1 P00352 3/20 0.57
HPGD P15428 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
TP53 P04637 1/20 0.57
HTT P42858 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
CYTH2 Q99418 1/20 0.57
TSHR P16473 3/20 0.56
CYP2C9 P11712 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
GABRG2 P18507 1/20 0.56
GABRB3 P28472 1/20 0.56
GABRA3 P34903 1/20 0.56
CYP19A1 P11511 1/20 0.54
ADAM17 P78536 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7322031 0.89 FFAR4 (0.74) FFAR4LMNAKEAP1ALDH1A1HPGD
SCHEMBL7322545 0.89 FFAR4 (0.65) FFAR4LMNAKEAP1TCF4CTNNB1
SCHEMBL7320167 0.87 FFAR4 (0.70) FFAR4LMNAKEAP1ALDH1A1HPGD
SCHEMBL5101263 0.86 TSHR (0.68) FFAR4LMNAALDH1A1HTTSMN1; SMN2
SCHEMBL7324979 0.86 LMNA (0.67) FFAR4LMNAKEAP1TCF4CTNNB1
SCHEMBL7322570 0.85 LMNA (0.65) FFAR4LMNATCF4CTNNB1ALDH1A1
SCHEMBL7312055 0.85 LMNA (0.65) FFAR4LMNAKEAP1TCF4CTNNB1
SCHEMBL7316540 0.83 LMNA (0.62) FFAR4LMNAKEAP1TCF4CTNNB1
SCHEMBL7308859 0.83 FFAR4 (0.74) FFAR4LMNATCF4CTNNB1ALDH1A1
SCHEMBL7311620 0.82 FFAR4 (0.52) FFAR4LMNATCF4CTNNB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1777214-A2 Novel aryloxy-alkyl-dialkylamines Wyeth (US) 2007-04-25 EP disclosed
EP-1025077-B1 NOVEL ARYLOXY-ALKYL-DIALKYLAMINES WYETH CORP (US) 2007-02-28 EP disclosed
EP-0938471-B1 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID CO (US) 2001-12-12 EP disclosed
US-6268504-B1 USED IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS AMERICAN HOME PRODUCTS CORPORATION 2001-07-31 US disclosed
US-6242605-B1 Aryloxy-alkyl-dialkylamines AMERICAN HOME PRODUCTS CORPORATION 2001-06-05 US disclosed
EP-1025077-A1 NOVEL ARYLOXY-ALKYL-DIALKYLAMINES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-08-09 EP disclosed
CN-1240429-A Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors AMERICAN CYANAMID CO (US) 2000-01-05 CN disclosed
US-6005102-A NOVEL INTERMEDIATES WHICH MAY BE USED IN THE PRODUCTION OF PHARMACEUTICAL COMPOUNDS FOR ANTI-ESTROGENIC AND MATRIX METALLOPROTEINASES-INHIBITING UTILITIES AMERICAN HOME PRODUCTS CORPORATION (US) 1999-12-21 US disclosed
US-5929097-A INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AMERICAN CYANAMID COMPANY (US) 1999-07-27 US disclosed
WO-1999019293-A1 NOVEL ARYLOXY-ALKYL-DIALKYLAMINES AMERICAN HOME PRODUCTS CORPORATION (US) 1999-04-22 WO disclosed